🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
3,385
Companies
1,062
Pipeline programs
18,156

Quick answer

NovaPharmaNews tracks 3,385 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

8 results for “TEZ” Clear

  1. atezolizumab

    TECENTRIQ

    INJECTION approved

    L01XC32

  2. atezolizumab and hyaluronidase-tqjs

    TECENTRIQ HYBREZA

    INJECTION approved

  3. bortezomib

    BORTEZOMIB ACCORD MAIA Biotechnology

    INJECTION approved

    L01XG01

  4. deutivacaftor / tezacaftor / vanzacaftor

    ALYFTREK Vertex Pharmaceuticals (Ireland) Limited

    R07AX33

  5. elexacaftor, ivacaftor, tezacaftor

    TRIKAFTA (COPACKAGED) Vertex Pharmaceuticals (Ireland) Limited

    ORAL approved

  6. tezacaftor

    SYMKEVI Vertex Pharmaceuticals (Ireland) Limited

    R07AX31

  7. tezepelumab

    TEZSPIRE

    R03DX11

  8. tezepelumab-ekko

    TEZSPIRE

    SUBCUTANEOUS approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 3,385 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources